STRYKER CORP (SYK) FY2026 Q2 P&L / Income Statement

STRYKER CORP (SYK) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

6,589,000,000 US dollars

Cost of sales

2,091,000,000 US dollars

Gross profit

4,498,000,000 US dollars

Total operating expenses

2,839,000,000 US dollars

Operating income

1,659,000,000 US dollars

Other income (expense), net (calculated)

negative 95,000,000 US dollars

Earnings before income taxes

1,564,000,000 US dollars

Income taxes

288,000,000 US dollars

Net earnings

1,276,000,000 US dollars

MedSurg and Neurotechnology - Endoscopy

1,004,000,000 US dollars

MedSurg and Neurotechnology - Instruments

1,003,000,000 US dollars

MedSurg and Neurotechnology - Medical

1,122,000,000 US dollars

MedSurg and Neurotechnology - Vascular

496,000,000 US dollars

Orthopaedics - Hips

479,000,000 US dollars

Orthopaedics - Knees

693,000,000 US dollars

Orthopaedics - Ortho Tech

717,000,000 US dollars

Orthopaedics - Spinal Implants

3,000,000 US dollars

Orthopaedics - Trauma and Extremities

1,072,000,000 US dollars

Research, development and engineering expenses

434,000,000 US dollars

Selling, general and administrative expenses

2,229,000,000 US dollars

Amortization of intangible assets

175,000,000 US dollars

Asset impairments

1,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.